Technical Analysis for AXSM - Axsome Therapeutics, Inc.
|Grade||Last Price||% Change||Price Change|
AXSM closed up 3.23 percent on Thursday, January 17, 2019, on 44 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
|See historical AXSM trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 17||Wide Bands||Range Expansion||0.00%|
|Jan 17||Overbought Stochastic||Strength||0.00%|
|Jan 17||Up 3 Days in a Row||Strength||0.00%|
|Jan 17||Up 4 Days in a Row||Strength||0.00%|
|Jan 16||Calm After Storm||Range Contraction||3.23%|
|Jan 16||Doji - Bearish?||Reversal||3.23%|
|Jan 16||Stochastic Reached Overbought||Strength||3.23%|
|Jan 16||Wide Bands||Range Expansion||3.23%|
|Jan 16||Overbought Stochastic||Strength||3.23%|
|Jan 16||Up 3 Days in a Row||Strength||3.23%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, develops therapies for the management and treatment of pain and other central nervous system disorders. Its product candidates include AXS-02, which is in Phase III trial for the treatment of pain in patients with complex regional pain syndrome; and AXS-05 for the treatment of agitation in patients with Alzheimer's disease and treatment resistant depression. The company is also developing AXS-02 for the treatment of knee osteoarthritis and chronic low back pain, as well as a preclinical development program AXS-06 for the treatment of chronic pain disorders. Axsome Therapeutics, Inc. was founded in 2012 and is based in New York, New York.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more AXSM news...
|52 Week High||9.16|
|52 Week Low||1.94|
|200-Day Moving Average||3.3292|
|50-Day Moving Average||3.8598|
|20-Day Moving Average||4.8035|
|10-Day Moving Average||7.262|
|Average True Range||0.8766|
|Chandelier Exit (Long, 3 ATRs )||6.5302|
|Chandelier Exit (Short, 3 ATRs )||4.5698|
|Upper Bollinger Band||10.2496|
|Lower Bollinger Band||-0.6426|
|Percent B (%b)||0.82|
|MACD Signal Line||0.9863|
|Market Cap||196.44 Million|
|Num Shares||23.6 Million|
|Price-to-Earnings (P/E) Ratio||-5.74|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||9.36|
|Resistance 3 (R3)||9.33||8.96||9.18|
|Resistance 2 (R2)||8.96||8.70||8.97||9.12|
|Resistance 1 (R1)||8.64||8.53||8.80||8.67||9.07|
|Support 1 (S1)||7.95||8.01||8.11||7.98||7.57|
|Support 2 (S2)||7.58||7.84||7.59||7.52|
|Support 3 (S3)||7.26||7.58||7.46|
|Support 4 (S4)||7.29|